| AB SICAV I-EMERGING MARKETS OPPORTUNITIES PORTFOLIO A CHF | RVI EMERGENTES | 41,42% | · | · | · |
| ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF USD (DIST) | RVI BIOTECNOLOGÍA | 41,41% | 67,43% | 46,21% | · |
| FIDELITY FUNDS-INSTITUTIONAL EMERGING MARKETS EQUITY I-ACC-USD | RVI EMERGENTES | 41,39% | 90,19% | 41,19% | 139,83% |
| UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) P-ACC | RVI EMERGENTES | 41,38% | 85,00% | 39,34% | 134,24% |
| AB SICAV I-EMERGING MARKETS OPPORTUNITIES PORTFOLIO I USD | RVI EMERGENTES | 41,35% | · | · | · |
| UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (SGD) P-ACC | RVI EMERGENTES | 41,34% | 85,03% | 39,24% | 134,34% |
| NORDEA 1-ASIAN SUSTAINABLE STARS EQUITY FUND BP-EUR | RVI ASIA EX-JAPÓN | 41,33% | 86,17% | 33,74% | · |
| NORDEA 1-ASIAN SUSTAINABLE STARS EQUITY FUND BP-USD | RVI ASIA EX-JAPÓN | 41,33% | 86,07% | 33,67% | · |
| BNP PARIBAS JAPAN SMALL CAP N JPYCAP | RVI JAPÓN SMALL/MID CAP | 41,32% | 87,94% | 75,75% | 145,95% |
| BGF NEXT GENERATION TECHNOLOGY S2 CHF (HEDGED) | RVI TECNOLOGÍA | 41,31% | 125,96% | 43,42% | · |
